This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Are Investors Undervaluing Molina (MOH) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina (MOH) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 21.48% and 2.93%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include: United States Cellular, Kirkland Lake Gold, Hasbro and Molina Healthcare
by Zacks Equity Research
Zacks.com featured highlights include: United States Cellular, Kirkland Lake Gold, Hasbro and Molina Healthcare
Buy 6 Top Stocks Set to Beat on Earnings in Q2 Today
by Nalak Das
Second-quarter 2019 earnings expectations have improved this month. In spite of a prolonged trade conflict with China, we do not see a broad-based decline in guidance by U.S. corporates.
Top Ranked Growth Stocks to Buy for July 30th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 30th.
Is a Beat in Store for Molina Healthcare (MOH) Q2 Earnings?
by Zacks Equity Research
Molina Healthcare's (MOH) second-quarter earnings are likely to be cushioned by its strategic divestitures as well as cost-reduction plans, partly offset by lower revenues.
Bet on These 4 Liquid Stocks for a Lucrative Portfolio
by Zacks Equity Research
Four top-ranked liquid stocks that can create a winning portfolio for investors.
Magellan Health (MGLN) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Magellan Health (MGLN) is likely to benefit from its Healthcare segment, partly offset by rise in expenses.
Molina (MOH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $135.50, marking a -0.66% move from the previous day.
Anthem's (ANTM) Q2 Earnings Beat Estimates, Increase Y/Y
by Zacks Equity Research
Anthem's (ANTM) second-quarter earnings gain from higher revenues.
Molina (MOH) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Molina (MOH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Centene's (CNC) Q2 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Centene's (CNC) second-quarter earnings benefit from higher revenues and operational efficiency.
Zacks.com featured highlights include: Amazon, Molina Healthcare, John Bean, Square and Martin Marietta
by Zacks Equity Research
Zacks.com featured highlights include: Amazon, Molina Healthcare, John Bean, Square and Martin Marietta
What to Expect for Universal Health's (UHS) Q2 Earnings
by Zacks Equity Research
Universal Health's (UHS) Q2 earnings are likely to gain from its strong segmental performances at Acute Care and Behavioral Health, partly offset by high costs.
What's in the Offing for Anthem's (ANTM) Earnings in Q2?
by Zacks Equity Research
Anthem's (ANTM) second-quarter earnings are likely to benefit from a solid revenue stream.
Ensign Group (ENSG) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Ensign Group (ENSG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
5 Stocks Look Primed for Solid Earnings Beat
by Sanghamitra Saha
Invest in top-ranked stocks that are likely to beat their earnings estimates in the upcoming releases.
Molina (MOH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $142.09, marking a +1.01% move from the previous day.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
Top Ranked Growth Stocks to Buy for July 17th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, July 17th.
Top Ranked Growth Stocks to Buy for July 16th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 16th.
Zacks.com featured highlights include: United States Cellular, Dropbox, Chipotle Mexican Grill and Molina Healthcare
by Zacks Equity Research
Zacks.com featured highlights include: United States Cellular, Dropbox, Chipotle Mexican Grill and Molina Healthcare
Should Value Investors Buy Molina (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina (MOH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $144.87, marking a +1.07% move from the previous day.
Is UnitedHealth (UNH) Stock a Buy Heading into Q2 2019 Earnings?
by Benjamin Rains
Shares of UnitedHealth Group (UNH) popped Friday after they surged Thursday to help spur the Dow Jones Industrial Average's rally. But should investors consider buying UNH stock ahead of its Q2 earnings results?